Neogen Chemicals has informed that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026, to consider and approve Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended on March 31, 2026; Recommendation of a final dividend, if any, on the equity shares of the Company, for the financial year ended March 31, 2026, subject to declaration and approval of the same by the shareholders at the ensuing 37th Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.
